CN101601750A - A kind of specific beriberi medicament - Google Patents
A kind of specific beriberi medicament Download PDFInfo
- Publication number
- CN101601750A CN101601750A CNA2009100654457A CN200910065445A CN101601750A CN 101601750 A CN101601750 A CN 101601750A CN A2009100654457 A CNA2009100654457 A CN A2009100654457A CN 200910065445 A CN200910065445 A CN 200910065445A CN 101601750 A CN101601750 A CN 101601750A
- Authority
- CN
- China
- Prior art keywords
- sheet
- vitamin
- beriberi
- parts
- clotrimazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a kind of specific beriberi medicament, mainly make: 3～12 parts of dried Alumens, 1～4 part in Semen Armeniacae Amarum, 0.25～1 part of Metronidazole Tablet, 0.15～1 part of nystatin sheet, 0.15～1 part of furaxone, 0.25～1 part of hydroxytetracycline tablet, vitamin B by the raw material of following parts by weight
10.15～1 part of sheet, vitamin B
210～30 parts of 0.25～1 part of sheet and clotrimazole creams.Among the present invention with the anti-microbial type medicine as main component, can kill the antibacterial, the fungus that cause beriberi, adding vitamin B group and ascorbic purpose is wound repairing, promotes healing, makes skin recover normal comparatively apace, dried Alumen makes agents area keep relatively dry, Semen Armeniacae Amarum relieves internal heat, and each component complements each other, and can fast and effeciently treat beriberi, the patient is got well, and the present invention simultaneously also has effect preferably to sweaty foot and foot odor.
Description
Technical field
The invention belongs to technical field of pharmaceuticals, relate to a kind of specific beriberi medicament.
Background technology
Beriberi is the popular name of tinea pedis, is a kind of extremely common fungal infection dermatoses, and the people of 70-80% has beriberi among the adult, is the weight difference, and increase the weight of the summer of being everlasting, and alleviate winter, also has the people not heal all the year round.Beriberi is a kind of infectious dermatosis, should avoid scratching, and as untimely treatment, can infect other position sometimes, as causes the tinea manuum and tinea unguium etc., is scratched because of itching sometimes, and the secondary bacterial infection can cause severe complications.At present, commercially available beriberi medicine can only be treated the beriberi that fungus or fungal infection cause mostly, but unsatisfactory to the beriberi of mixed type infection, for example, beriberi such as bacterial infection, erosion, a pustule, a vesicle, edema is not had the specific drug of disposable whole healings.
Summary of the invention
The purpose of this invention is to provide the tangible specific beriberi medicament of a kind of curative effect.
For achieving the above object, the present invention is by the following technical solutions: a kind of specific beriberi medicament, mainly make: 3～12 parts of dried Alumens, 1～4 part in Semen Armeniacae Amarum, 0.25～1 part of Metronidazole Tablet, 0.15～1 part of nystatin sheet, 0.15～1 part of furaxone, 0.25～1 part of hydroxytetracycline tablet, vitamin B by the raw material of following parts by weight
10.15～1 part of sheet, vitamin B
210～30 parts of 0.25～1 part of sheet and clotrimazole creams.
Also add the raw material that following parts by weight are arranged: 0.15～1 part of Chloramphenicol Tablets, vitamin B
60.25～1 part of sheet, 0.25～1 part of VITAMIN C TABLET.
The usage ratio of described dried Alumen and Semen Armeniacae Amarum is 3: 1.
The specification of described clotrimazole cream is to contain clotrimazole 0.01g in every g clotrimazole cream.
Described nystatin sheet specification is 500,000 units.
Medicament mixed, pulverizing that earlier will be except that clotrimazole cream during preparation be then with the clotrimazole cream mix homogeneously.
With using with joining, cream, the powder hybrid medicine with mixing is applied in the affected part then during use, cures in general 3-7 days.
Composition of the present invention mainly adopts the medicine of anti-microbial type, Metronidazole Tablet, nystatin sheet, furaxone, hydroxytetracycline tablet, clotrimazole cream, six kinds of compositions of Chloramphenicol Tablets are antimicrobial component, concrete antibiotic situation is: Metronidazole Tablet is an anti-anaerobic agent, is difficult for producing the antibacterial drug resistance; The nystatin sheet is for curing mainly mycete; Furaxone cures mainly antibacterial; Hydroxytetracycline tablet is a broad-spectrum antibacterial agent; Chloramphenicol Tablets is the biocidal property broad ectrum antibiotic; Clotrimazole cream is used for the treatment of the tinea bacterium, also plays a kind of effect of paste carrier in the present invention, makes medicine of the present invention form paste and can smear to the affected part; Dried, dehumidifying that dried Alumen is held back makes agents area keep relatively dry; Semen Armeniacae Amarum relieves internal heat, subsides a swelling, and can control all skin ulcers, swell and ache; The vitamin B group wound repairing is specially: vitamin B
2Promote cell regeneration and growth, make newborn skin grow vitamin B rapidly
1Promote newborn skin growth, vitamin B
6Raise immunity improves the ability of opposing antibacterial; Vitamin C resists bad blood, promotes wound healing.Among the present invention with the anti-microbial type medicine as main component, can kill the antibacterial, the fungus that cause beriberi, adding vitamin B group and ascorbic purpose is wound repairing, promotes healing, makes skin recover normal comparatively apace, dried Alumen makes agents area keep relatively dry, Semen Armeniacae Amarum relieves internal heat, and each component complements each other, and can fast and effeciently treat beriberi, the patient is got well, and the present invention simultaneously also has curative effect preferably to sweaty foot and foot odor.
Earlier the medicine except that clotrimazole cream is pulverized during preparation, then with the clotrimazole cream mix homogeneously, during use this mixture is smeared to the affected part, 1-3 time on the one, 3-7 days is a course of treatment, and general medication can be cured a course of treatment, can continue behind the transference cure to smear and consolidate in 2-3 days, patient for rebound phenomenon is arranged after the only a few healing uses medicine of the present invention to smear when the recurrence sign is arranged at first immediately, the may command recurrence.
Through research and nearly 2000 routine patients use proof for many years, medicine of the present invention is splendid to the therapeutic effect of beriberi, to fester, pain, play pustule, get blister, flow yellow fluid, the edema type beriberi all has ideal curative effect, among the nearly 2000 routine patients that treated, men and women's half-and-half, patient age reckling 12 years old, the maximum 65 years old.Have the 1940 routine patients of surpassing to use and cured fully in 3-7 days, cure rate reaches more than 97%, and not recurrence again after curing; Effective when other has 20 routine patients to use medicine of the present invention in early days, but recur after half a year, routine patient uses effectively surplus in the of nearly 10 in addition, but can recurrence after the drug withdrawal, selects to prolong to use thoroughly healing after 1-2 the course of treatment; Wherein only have 3-4 example patient result of use not obvious, inefficiency is extremely low.Sweaty foot obviously reduces after most of patients is used the back to reflect, used medicine of the present invention, the foot odor situation be improved significantly, illustrate that the present invention also has better curative effect to sweaty foot and foot odor.
The specific embodiment
Embodiment 1: 3 parts of dried Alumens, 1 part in Semen Armeniacae Amarum, 0.25 part of Metronidazole Tablet, 0.15 part of nystatin sheet, 0.15 part of furaxone, 0.25 part of hydroxytetracycline tablet, vitamin B
10.15 part of sheet, vitamin B
210 parts of 0.25 part of sheet and clotrimazole creams.
Embodiment 2: 9 parts of dried Alumens, 3 parts in Semen Armeniacae Amarum, 0.8 part of Metronidazole Tablet, 0.6 part of nystatin sheet, 0.6 part of furaxone, 0.8 part of hydroxytetracycline tablet, vitamin B
10.8 part of sheet, vitamin B
215 parts of 0.8 part of sheet and clotrimazole creams.
Embodiment 3: 12 parts of dried Alumens, 4 parts in Semen Armeniacae Amarum, 1 part of Metronidazole Tablet, 1 part of nystatin sheet, 1 part of furaxone, 1 part of hydroxytetracycline tablet, vitamin B
11 part of sheet, vitamin B
225 parts of 1 part of sheet and clotrimazole creams.
Embodiment 4: 10 parts of dried Alumens, 2.5 parts in Semen Armeniacae Amarum, 0.6 part of Metronidazole Tablet, 0.6 part of nystatin sheet, 0.6 part of furaxone, 0.6 part of hydroxytetracycline tablet, vitamin B
10.6 part of sheet, vitamin B
20.6 part of sheet, 0.6 part of Chloramphenicol Tablets, vitamin B
628 parts of 0.6 part of sheet, 0.6 part of VITAMIN C TABLET and clotrimazole creams.
Embodiment 5: 3 parts of dried Alumens, 1 part in Semen Armeniacae Amarum, 0.25 part of Metronidazole Tablet, 0.15 part of nystatin sheet, 0.15 part of furaxone, 0.25 part of hydroxytetracycline tablet, vitamin B
10.15 part of sheet, vitamin B
20.25 part of sheet, 0.15 part of Chloramphenicol Tablets, vitamin B
615 parts of 0.25 part of sheet, 0.25 part of VITAMIN C TABLET and clotrimazole creams.
Embodiment 6: 12 parts of dried Alumens, 4 parts in Semen Armeniacae Amarum, 1 part of Metronidazole Tablet, 1 part of nystatin sheet, 1 part of furaxone, 1 part of hydroxytetracycline tablet, vitamin B
11 part of sheet, vitamin B
21 part of sheet, 1 part of Chloramphenicol Tablets, vitamin B
630 parts of 1 part of sheet, 1 part of VITAMIN C TABLET and clotrimazole creams.
Umber among the above embodiment is parts by weight, and the specification of clotrimazole cream is to contain clotrimazole 0.01g in every g clotrimazole cream, and nystatin sheet specification is 500,000 units.
Medicament mixed, pulverizing that all earlier will be except that clotrimazole cream when embodiment 1-6 prepares, then with the clotrimazole cream mix homogeneously, cream, powder hybrid medicine with mixing during use be applied in the affected part, cured in general 3-7 days.
Raw materials used specification and manufacturer among the present invention:
Metronidazole Tablet: specification 0.2 gram, Heng Shan, Shanghai pharmaceutcal corporation, Ltd;
Nystatin sheet: specification 500,000 units, Shanghai Pharmaceutical's letter friendship pharmacy head factory;
Furaxone: specification 0.1 gram, the prosperous grand pharmaceutical factory in Anhui;
Hydroxytetracycline tablet: specification 0.125 gram, the popular share in Linzhou City pharmaceutcal corporation, Ltd;
Vitamin B
2Sheet: 5 milligrams of specifications, Guanji, Hubei Pharmaceutical limited company;
VITAMIN C TABLET: specification 0.1 gram, the Chang Le of Xinxiang City pharmaceutical Co. Ltd;
Chloramphenicol Tablets: specification 0.25 gram, Jiangsu zero diopter pharmacy (group) company limited;
Vitamin B
1Sheet: 10 milligrams of specifications, pharmaceutical Co. Ltd in the another name for Sichuan Province, Sichuan;
Vitamin B
6Sheet: 10 milligrams of specifications, Nanyang Pukang Pharmaceutical Co;
Clotrimazole cream: specification 10g, the concentric pharmaceutcal corporation, Ltd in Xinxiang.
Model case:
Case 1: the Wang, the man, 46 years old, the rural migrant worker suffered from beriberi for many years, fester between toe, the whiting of dipping place, granulation exposes, and the many places breach once used daktarin not cure, and constantly recurrence.The use embodiment of the invention 2 Drug therapys after this institute goes to a doctor, smear 2-3 every day, two days later, and the convergence of festering, breach reduces, and disease disappeared substantially in the 3rd day, the 5th day basic the healing, the continuation use was consolidated curative effect and thoroughly cure in one week, paid a return visit after 1 year and did not have recurrence.
Case 2: Liu, the woman 18 years old, suffered from beriberi 4 years, sole swelling when recurrence, be dispersed in pustule, use the Drug therapy of the embodiment of the invention 3, swelling disappears after three days, the pustule convergence, disease disappears after five days, and it is normal that skin recovers, and pays a return visit through half a year, does not have the recurrence sign.
Case 3: Liu, woman, student, 21 years old, suffer from vesicle type beriberi, sole, instep all have the big phlysis of foxtail millet grain during prescription on individual diagnosis, be mixed with red pimple, the erythra surrounding skin is general red, very itches, use the Drug therapy of the embodiment of the invention 4, two days later, gargalesthesia disappears, vesicle, pimple obviously reduced in the 3rd day, continued to use a week, and disease disappears, it is normal that skin recovers, and paying a return visit through half a year does not have recurrence.
Case 4: Zhao, man, 45 years old, the cadre suffers from beriberi for many years, bipod second and third, four toe rednesses, sufferings, the stream yellow fluid is after the use embodiment of the invention 5 medicines are smeared three days, redness, the sufferings sense disappears, and liquid oozes out obvious minimizing, after one week, disease disappears, and it is normal that skin recovers, thoroughly cure after continuing to consolidate in one week of medication curative effect, after 1 year, pay a return visit and do not have recurrence.
Case 5: Wang, man, 38 years old, driver, suffer from beriberi for many years, cast off a skin breach between toe, very itch, once use multiple beriberi medicine treatments such as newly fragile, curative effect is not good enough, often recurrence, the patient is very painful, smears the embodiment of the invention one week of 6 medicines, cast off a skin, breach reduces, gargalesthesia alleviates, and continues one week of medication, disease disappears substantially, continues 2 weeks of medication and cures, and pays a return visit after half a year and does not have recurrence.
Case 6: go into business certain, man, 26 years old, the rural migrant worker suffers from sweaty foot, foot odor for many years, uses the Compound Flavescent Sophora and Salicylic Acid Powder soaking therapy at ordinary times, sb.'s illness took a favorable turn for some time in meeting, but after a while, the state of an illness can recur again, uses the medicine of the embodiment of the invention 1 to smear a week, sweaty foot, foot odor obviously alleviate, continuing to use a week healing, the recurrence of return visit postmenstruation nothing.
Claims (6)
1, a kind of specific beriberi medicament is characterized in that mainly being made by the raw material of following parts by weight: 3～12 parts of dried Alumens, 1～4 part in Semen Armeniacae Amarum, 0.25～1 part of Metronidazole Tablet, 0.15～1 part of nystatin sheet, 0.15～1 part of furaxone, 0.25～1 part of hydroxytetracycline tablet, vitamin B
10.15～1 part of sheet, vitamin B
210～30 parts of 0.25～1 part of sheet and clotrimazole creams.
2, specific beriberi medicament as claimed in claim 1 is characterized in that: also add the raw material that following parts by weight are arranged: 0.15～1 part of Chloramphenicol Tablets, vitamin B
60.25～1 part of sheet, 0.25～1 part of VITAMIN C TABLET.
3, specific beriberi medicament as claimed in claim 1 or 2 is characterized in that: the usage ratio of described dried Alumen and Semen Armeniacae Amarum is 3: 1.
4, specific beriberi medicament as claimed in claim 3 is characterized in that: the specification of described clotrimazole cream is to contain clotrimazole 0.01g in every g clotrimazole cream.
5, specific beriberi medicament as claimed in claim 4 is characterized in that: described nystatin sheet specification is 500,000 units.
6, specific beriberi medicament as claimed in claim 5 is characterized in that: medicament mixed, pulverizing that earlier will be except that clotrimazole cream during preparation, and then with the clotrimazole cream mix homogeneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100654457A CN101601750B (en) | 2009-07-15 | 2009-07-15 | Specific beriberi medicament |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100654457A CN101601750B (en) | 2009-07-15 | 2009-07-15 | Specific beriberi medicament |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101601750A true CN101601750A (en) | 2009-12-16 |
| CN101601750B CN101601750B (en) | 2011-09-14 |
Family
ID=41467742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100654457A Expired - Fee Related CN101601750B (en) | 2009-07-15 | 2009-07-15 | Specific beriberi medicament |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101601750B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727515A (en) * | 2011-03-29 | 2012-10-17 | 赵文志 | Medicinal preparation for treating dermatophytosis |
| CN103623106A (en) * | 2013-11-11 | 2014-03-12 | 青岛佰众化工技术有限公司 | Pharmaceutical foot bath composition for treating beriberi |
| CN103933064A (en) * | 2014-04-27 | 2014-07-23 | 岳素芝 | Fungus remover |
| CN104027467A (en) * | 2014-06-23 | 2014-09-10 | 王诺生 | Anti-inflammatory medicament capable of treating beriberi and preparation method thereof |
| US8883747B1 (en) * | 2013-10-09 | 2014-11-11 | Craig W. Carver | Topical antifungal compositions and methods of use thereof |
| CN107853757A (en) * | 2017-11-13 | 2018-03-30 | 曾志煌 | A kind of comfortable wear-resistant healthcare silk stocking of ship type |
| CN113797223A (en) * | 2020-06-17 | 2021-12-17 | 徐旺 | Ointment for treating beriberi |
-
2009
- 2009-07-15 CN CN2009100654457A patent/CN101601750B/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727515A (en) * | 2011-03-29 | 2012-10-17 | 赵文志 | Medicinal preparation for treating dermatophytosis |
| US8883747B1 (en) * | 2013-10-09 | 2014-11-11 | Craig W. Carver | Topical antifungal compositions and methods of use thereof |
| CN103623106A (en) * | 2013-11-11 | 2014-03-12 | 青岛佰众化工技术有限公司 | Pharmaceutical foot bath composition for treating beriberi |
| CN103933064A (en) * | 2014-04-27 | 2014-07-23 | 岳素芝 | Fungus remover |
| CN104027467A (en) * | 2014-06-23 | 2014-09-10 | 王诺生 | Anti-inflammatory medicament capable of treating beriberi and preparation method thereof |
| CN104027467B (en) * | 2014-06-23 | 2017-11-03 | 王诺生 | It is a kind of to treat antiphlogistic of tinea pedis and preparation method thereof |
| CN107853757A (en) * | 2017-11-13 | 2018-03-30 | 曾志煌 | A kind of comfortable wear-resistant healthcare silk stocking of ship type |
| CN113797223A (en) * | 2020-06-17 | 2021-12-17 | 徐旺 | Ointment for treating beriberi |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101601750B (en) | 2011-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101601750B (en) | Specific beriberi medicament | |
| US9387227B2 (en) | Method for treatment of sores and lesions of the skin | |
| CN101468039B (en) | Method for preparing compound double-layer sustained-release medicinal membrane for treating oral mucosal disease | |
| CN103070914A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method thereof | |
| CN102258609A (en) | Sanhuang antipruritic liniment and its preparation method | |
| CN101874809A (en) | Local anti-inflammatory external medicinal composition using glycerol DMSO mixed solvent | |
| CN101612278B (en) | Medicine for external application for treating pyogenic type contaminated wounds | |
| CN102178810B (en) | Chinese medicinal paste film for treating skin ulcer and preparation method thereof | |
| CN101259149A (en) | Tinctura for treating beriberi | |
| CN101306163A (en) | Zhixue shengji powder | |
| CN1269495C (en) | Medicinal powder for treating beriberi | |
| CN102920997B (en) | Compound tinea ointment | |
| CN101085069B (en) | Medicine for curing beriberi | |
| CN1843366A (en) | Burn-treating liquid | |
| CN1435225A (en) | Medical ointment Jiaoxuanxiao for treating beriberi | |
| CN101564426B (en) | Medicament for external use for treating onychomycosis | |
| CN101342190A (en) | Medicament composition for treating beriberi | |
| CN100423735C (en) | Traditional Chinese medicine for treating haemorrhoids | |
| CN1063632C (en) | External use liniment for curing dermatosis | |
| CN103285234A (en) | Traditional Chinese medicine cuttlebone and bletilla rhizome powder for treatment of peptic ulcer | |
| CN100536866C (en) | Western and Chinese medicine integrated ointment for treating ulcer surface of wound on skin | |
| CN104173877A (en) | Traditional Chinese medicine preparation for quick wound healing and preparation method of traditional Chinese medicine preparation for quick wound healing | |
| CN102961544A (en) | Traditional chinese medicine bedsore powder | |
| CN105560837A (en) | Drug for treating skin injuries and preparation method thereof | |
| CN104814914A (en) | Chinese herbal medicine acne removal facial mask and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20130715 |